SMTL ID : 7jvm.1 (1 other biounit)

Non-receptor Protein Tyrosine Phosphatase SHP2 in Complex with Allosteric Inhibitor TNO155

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.17 Å

Oligo State

monomer

Ligands

1 x VKS: (3S,4S)-8-{6-amino-5-[(2-amino-3-chloropyridin-4-yl)sulfanyl]pyrazin-2-yl}-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine(Non-covalent)

VKS.1: 18 residues within 4Å: Chain A: T.108, E.110, R.111, F.113, H.114, N.217, T.218, T.219, E.249, E.250, T.253, L.254, Q.257, D.489, P.491, K.492, Q.495 Ligands: PO4.4 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:P.491 Hydrogen bonds: A:R.111, A:F.113, A:E.250, A:T.253 Water bridges: A:K.492 pi-Cation interactions: A:R.111

3 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 6 residues within 4Å: Chain A: R.32, S.34, K.35, S.36, N.37, T.42 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.35, A:S.36, A:N.37 Salt bridges: A:R.32 PO4.3: 2 residues within 4Å: Chain A: R.138, S.140 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:R.138 PO4.4: 4 residues within 4Å: Chain A: R.111, N.217, K.492 Ligands: VKS.1 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:N.217, A:D.489 Water bridges: A:R.111, A:R.111 Salt bridges: A:R.111, A:K.492

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

LaMarche, M.J. et al., Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. J.Med.Chem. (2020)

Release Date

2020-09-23

Peptides

Tyrosine-protein phosphatase non-receptor type 11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein phosphatase non-receptor type 11

Related Entries With Identical Sequence